BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7896657)

  • 1. Case study: paradoxical response to naltrexone treatment of self-injurious behavior.
    Benjamin S; Seek A; Tresise L; Price E; Gagnon M
    J Am Acad Child Adolesc Psychiatry; 1995 Feb; 34(2):238-42. PubMed ID: 7896657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid antagonist effects on self-injury in adults with mental retardation: response form and location as determinants of medication effects.
    Thompson T; Hackenberg T; Cerutti D; Baker D; Axtell S
    Am J Ment Retard; 1994 Jul; 99(1):85-102. PubMed ID: 7946257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effects of naltrexone on autistic behavior.
    Zingarelli G; Ellman G; Hom A; Wymore M; Heidorn S; Chicz-DeMet A
    Am J Ment Retard; 1992 Jul; 97(1):57-63. PubMed ID: 1497864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior.
    Sandman CA; Barron JL; Colman H
    Am J Ment Retard; 1990 Jul; 95(1):93-102. PubMed ID: 2167107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
    Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
    Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of naltrexone on self-injurious behavior.
    Sandman CA; Hetrick W; Taylor DV; Marion SD; Touchette P; Barron JL; Martinezzi V; Steinberg RM; Crinella FM
    Am J Ment Retard; 2000 Mar; 105(2):103-17. PubMed ID: 10755174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
    Roth AS; Ostroff RB; Hoffman RE
    J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-injurious behavior and the efficacy of naltrexone treatment: a quantitative synthesis.
    Symons FJ; Thompson A; Rodriguez MC
    Ment Retard Dev Disabil Res Rev; 2004; 10(3):193-200. PubMed ID: 15611982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-injurious behavior in the developmentally disabled: pharmacologic treatment.
    Osman OT; Loschen EL
    Psychopharmacol Bull; 1992; 28(4):439-49. PubMed ID: 1296222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone].
    Leboyer M; Bouvard MP; Launay JM; Recasens C; Plumet MH; Waller-Perotte D; Tabuteau F; Bondoux D; Dugas M
    Encephale; 1993; 19(2):95-102. PubMed ID: 8275903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone in autistic children: behavioral symptoms and attentional learning.
    Campbell M; Anderson LT; Small AM; Adams P; Gonzalez NM; Ernst M
    J Am Acad Child Adolesc Psychiatry; 1993 Nov; 32(6):1283-91. PubMed ID: 8282676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone open trial with a 5-year-old-boy. A social rebound reaction.
    Lensing P; Klingler D; Lampl C; Leboyer M; Bouvard M; Plumet MH; Panksepp J
    Acta Paedopsychiatr; 1992; 55(3):169-73. PubMed ID: 1414352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.
    Willemsen-Swinkels SH; Buitelaar JK; van Engeland H
    Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.
    Willemsen-Swinkels SH; Buitelaar JK; Nijhof GJ; van England H
    Arch Gen Psychiatry; 1995 Sep; 52(9):766-73. PubMed ID: 7654128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone decreases self-injurious behavior.
    Herman BH; Hammock MK; Arthur-Smith A; Egan J; Chatoor I; Werner A; Zelnik N
    Ann Neurol; 1987 Oct; 22(4):550-2. PubMed ID: 3481242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-endorphin disregulation in autistic and self-injurious behavior: a neurodevelopmental hypothesis.
    Sandman CA
    Synapse; 1988; 2(3):193-9. PubMed ID: 2463689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extinction of self-injurious escape behavior with and without instructional fading.
    Zarcone JR; Iwata BA; Vollmer TR; Jagtiani S; Smith RG; Mazaleski JL
    J Appl Behav Anal; 1993; 26(3):353-60. PubMed ID: 8407683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine treatment of severe self-injury in young adults with mental retardation.
    Ricketts RW; Goza AB; Ellis CR; Singh YN; Singh NN; Cooke JC
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):865-9. PubMed ID: 8340311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The neuroendocrinological examinations in mentally retarded boy with self-injurious behavior (SIB) and the effect of naloxone, clomipramine and sulpiride on SIB].
    Sugama S; Kusano K; Okazaki M; Eto Y
    Rinsho Shinkeigaku; 1992 Aug; 32(8):890-2. PubMed ID: 1490319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-injurious behavior in the developmentally disabled: assessment techniques.
    Loschen EL; Osman OT
    Psychopharmacol Bull; 1992; 28(4):433-8. PubMed ID: 1296221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.